Search Results - "Areses Manrique, María Carmen"

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report by Arias Ron, David, Labandeira, Carmen M., Areses Manrique, María Carmen, Sampedro Domarco, Paula, Abdulkader, Ihab, García-Mata, Jesús, Rolfo, Christian, González-Rivas, Diego, Fírvida, Jose Luis

“…In a patient who had been diagnosed of located squamous cell lung carcinoma, pneumonectomy, and adjuvant chemotherapy were performed. Brain recurrence and…”
Get full text

The long road from molecular biology to clinical practice in colorectal cancer by Areses Manrique, María Carmen, Iglesias Rey, Leticia, Cubiella, Joaquín

Get more information

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis by García-González, Jorge, Ruiz-Bañobre, Juan, Afonso-Afonso, Francisco J, Amenedo-Gancedo, Margarita, Areses-Manrique, María Del Carmen, Campos-Balea, Begoña, Casal-Rubio, Joaquín, Fernández-Núñez, Natalia, Fírvida Pérez, José Luis, Lázaro-Quintela, Martín, Pérez Parente, Diego, Crama, Leonardo, Ruiz-Gracia, Pedro, Santomé-Couto, Lucía, León-Mateos, Luis

“…The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option…”
Get full text

The long road from molecular biology to clinical practice in colorectal cancer by Areses Manrique, María Carmen, Iglesias Rey, Leticia, Cubiella, Joaquín

Get full text

Real-world clinical experience of the Galician Lung Cancer Group: Afatinib in patients with EGFR positive mutation by Agraso Busto, Sara, Varela, Vanesa, Fernández Núñez, Natalia, Firvida, Jose-luis, Santomé, Lucía, Afonso, Francisco Javier, Azpitarte, Cristina, De Dios Alvarez, Noemi, Garcia, Jorge, Campos Balea, Begoña, Areses Manrique, Maria Carmen, Pereiro Corbacho, Diego, Huidobro, Gerardo, Lazaro Quintela, Martin, Casal Rubio, Joaquín

“…Abstract only e20654 Background: Treatment with tyrosine kinasa inhibitors has been a revolution for the patients with non-small cell lung cancer and EGFR…”
Get full text

Efficacy and safety of Crizotinib in patients with ALK positive non small cell lung cancer (NSCLC): Real-world findings by Raposeiras, Cristina Azpitarte, De Dios Alvarez, Noemi, Garcia, Jorge, Areses Manrique, Maria Carmen, Fernández Núñez, Natalia, Afonso Afonso, Francisco J., Amenedo, Margarita, Veiga, Nazaret Quiroga, Cebey, Victor, Lazaro Quintela, Martin, Firvida, Jose-luis, Campos Balea, Begoña, Ruiz Bañobre, Juan, Varela Pose, Vanesa, Agraso Busto, Sara, Constenla, Manuel

“…Abstract only e20636 Background: First or second line crizotinib has shown greater efficacy in clinical trials than chemotherapy in patients with NSCLC ALK…”
Get full text

Third and successive–lines of chemotherapy in NSCLC patients without therapeutic targets: Experience of the Grupo Gallego de Cáncer de Pulmón by Afonso Afonso, Francisco Javier, Fernández Núñez, Natalia, Vilchez Simo, Rocio, Firvida, Jose-luis, De Dios Alvarez, Noemi, Campos Balea, Begoña, Ruiz Bañobre, Juan, Areses Manrique, Maria Carmen, Agraso Busto, Sara, Carmona Campos, Marta, De Paz Árias, Laura María, Cameselle Garcia, Soledad, Pereiro Corbacho, Diego, Vázquez Estévez, Sergio, García Mata, Jesús, Casal Rubio, Joaquin, Constenla, Manuel

“…Abstract only e20579 Background: The current treatment of advanced non-small cell lung cancer (NSCLC) is conditioned by the presence of molecular and…”
Get full text

Galician lung cancer group: Afatinib´s data as first-line treatment for elderly patients by Agraso Busto, Sara, Varela, Vanesa, Fernández Núñez, Natalia, Firvida, Jose-luis, Santomé, Lucía, Afonso, Francisco Javier, Azpitarte, Cristina, De Dios Alvarez, Noemi, Garcia, Jorge, Campos Balea, Begoña, Areses Manrique, Maria Carmen, Pereiro Corbacho, Diego, Huidobro, Gerardo, Lazaro Quintela, Martin, Casal Rubio, Joaquín

“…Abstract only e20662 Background: There are scarcy data or studies on safety and efficacy of afatinib in elderly patients. Methods: Retrospective study on…”
Get full text

Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group by Arias Ron, David, Areses Manrique, Maria Carmen, Mosquera Martínez, Joaquín, García González, Jorge, Afonso Afonso, Francisco Javier, Lázaro Quintela, Martín, Fernández Núñez, Natalia, Azpitarte Raposeiras, Cristina, Amenedo Gancedo, Margarita, Santomé Couto, Lucía, García Campelo, María Rosario, Muñoz Iglesias, Jose, Ruiz Bañobre, Juan, Vilchez Simo, Rocío, Casal Rubio, Joaquín, Campos Balea, Begoña, Carou Frieiro, Iria, Alonso-Jaudenes Curbera, Guillermo, Anido Herranz, Urbano, García Mata, Jesús, Fírvida Pérez, Jose Luis

“…Nivolumab is an anti PD1 immunotherapy drug approved for advanced Non-Small Cell Lung Cancer (NSCLC) patients who previously received at least one prior line…”
Get full text

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report by Arias Ron, David, Labandeira, Carmen M, Areses Manrique, María Carmen, Sampedro Domarco, Paula, Abdulkader, Ihab, García-Mata, Jesús, Rolfo, Christian, González-Rivas, Diego, Fírvida, Jose Luis

Get full text